Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Halozyme Therapeutics (HALO)
NASDAQ:HALO
Halozyme (HALO) Financial Statements
682 Followers
Halozyme Financial Overview
| Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 181.50M | $ 208.98M | $ 152.37M | $ 117.28M | $ 102.00M |
| Gross Profit | $ 139.38M | $ 161.66M | $ 118.42M | $ 101.36M | $ 80.42M |
| EBIT | $ 75.36M | $ 81.22M | $ 33.12M | $ 76.17M | $ 56.87M |
| EBITDA | $ 82.47M | $ 110.42M | $ 45.66M | $ 76.95M | $ 57.64M |
| Net Income Common Stockholders | $ 57.70M | $ 61.63M | $ 22.68M | $ 60.11M | $ 66.77M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 362.79M | $ 265.58M | $ 209.36M | $ 786.14M | $ 740.92M |
| Total Assets | $ 1.84B | $ 1.86B | $ 1.78B | $ 1.16B | $ 1.10B |
| Total Debt | $ 1.51B | $ 1.50B | $ 1.25B | $ 877.64M | $ 876.67M |
| Net Debt | $ 1.14B | $ 1.24B | $ 1.04B | $ 91.50M | $ 135.75M |
| Total Liabilities | $ 1.67B | $ 1.77B | $ 1.49B | $ 901.99M | $ 907.48M |
| Stockholders Equity | $ 169.80M | $ 96.99M | $ 293.17M | $ 260.26M | $ 196.95M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 80.11M | $ 68.63M | $ 39.26M | $ 47.31M | $ 82.36M |
| Operating Cash Flow | $ 82.45M | $ 69.64M | $ 40.23M | $ 47.80M | $ 82.52M |
| Investing Cash Flow | $ -1.75M | $ -1.01M | $ -434.95M | $ -49.30M | $ -299.47M |
| Financing Cash Flow | $ 6.33M | $ -12.40M | $ 367.82M | $ 624.00K | $ -156.01M |